A session at the Hematology/Oncology Pharmacy Association Virtual Annual Conference provided an overview of how treatment options are changing with potential new therapies in development for patients with non-small cell lung cancer.
Kristin Coppock, MA, Managing Editor
Advertisement
Articles by Kristin Coppock, MA, Managing Editor
Political insiders Donna L. Brazile and Michael Steele spoke to NASP members about which issues may concern them most and getting involved in the political process.
Advertisement
Latest Updated Articles
HOPA 2021: New Therapies on the Horizon for Advanced NSCLCPublished: April 13th 2021 | Updated:
Health Care Issues are Key Topics for Many Voters in the Presidential ElectionPublished: September 17th 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
CDC Layoffs Raise Questions About the Future of Public Health Surveillance
2
From $200,000 in Student Loan Debt to Becoming a 7-Figure Pharmacist
3
FDA Approves Updated Indication for Upadacitinib in Patients With IBD
4
Inhaled Insulin Demonstrates Comparable Safety, Lung Function, and Efficacy to Injectable Insulin in Type 1 Diabetes
5
